ScoreWhy is Castle Biosciences, Inc. ?
1
The company has declared Negative results for the last 5 consecutive quarters
- NET PROFIT(9M) At USD -20.6 MM has Grown at -57.02%
- INTEREST(HY) At USD 0.16 MM has Grown at 44.95%
- DEBT-EQUITY RATIO (HY) Highest at -48.75 %
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 11.69%, its profits have fallen by -242.1%
3
Underperformed the market in the last 1 year
- The stock has generated a return of 11.69% in the last 1 year, much lower than market (S&P 500) returns of 25.41%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Castle Biosciences, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Castle Biosciences, Inc.
11.69%
-0.13
67.95%
S&P 500
25.41%
1.92
13.25%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
40.60%
EBIT Growth (5y)
-225.27%
EBIT to Interest (avg)
-44.30
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.60
Sales to Capital Employed (avg)
0.67
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.49
EV to EBIT
-9.61
EV to EBITDA
-201.84
EV to Capital Employed
2.25
EV to Sales
1.20
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-23.41%
ROE (Latest)
-5.34%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend1What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -49.54% (YoY
-9What is not working for the Company
NET PROFIT(9M)
At USD -20.6 MM has Grown at -57.02%
INTEREST(HY)
At USD 0.16 MM has Grown at 44.95%
DEBT-EQUITY RATIO
(HY)
Highest at -48.75 %
OPERATING PROFIT(Q)
Lowest at USD -14.48 MM
OPERATING PROFIT MARGIN(Q)
Lowest at -17.3 %
Here's what is working for Castle Biosciences, Inc.
Raw Material Cost
Fallen by -49.54% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Castle Biosciences, Inc.
Net Profit
At USD -20.6 MM has Grown at -57.02%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Interest
At USD 0.16 MM has Grown at 44.95%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Operating Profit
Lowest at USD -14.48 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (USD MM)
Operating Profit Margin
Lowest at -17.3 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Debt-Equity Ratio
Highest at -48.75 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
